My SciELO
Services on Demand
Article
Indicators
- Cited by SciELO
Related links
- Similars in SciELO
Share
Revista Cubana de Angiología y Cirugía Vascular
On-line version ISSN 1682-0037
Abstract
MARTINEZ GALVEZ, Ifran and RODRIGUEZ RODRIGUEZ, Yasser. Diabetic foot ulcer treated with Heberprot-P®. Rev Cubana Angiol Cir Vasc [online]. 2020, vol.21, n.1 Epub May 20, 2020. ISSN 1682-0037.
Introduction:
Diabetes mellitus each year increases its incidence among the diagnosed and undiagnosed cases at the global level. Since this disease brings as a consequence a neuropathic and vascular damage, diabetic foot ulcers are considered to be the main cause of non-traumatic amputations. Prompt treatment with Heberprot-P® has improved the healing of these ulcers.
Objective:
To characterize patients with diabetic foot ulcer treated with Heberprot-P®.
Methods:
Retrospective descriptive study in 312 individuals diagnosed with diabetic foot ulcer treated with Heberprot-P® in "General Calixto García Iñiguez" University-Teaching- Clinical-Surgical Hospital from 2013 to 2017. The variables collected were: age, sex, type of diabetes, Wagner, vascular damage, dosage, evolution.
Results:
79.7% of the cases were 50 or more years old; men predominated being the 63.4% and 93.6% presented diagnosis of diabetes mellitus type 2. The 35% of the ulcers were in stage 3 of Wagner classification and the most frequently dose range used was 5 to 10 dosages. Vascular damage was observed in the 23.8%, with 76.6% of total healing and only the 8.9% were amputated.
Conclusions:
Men over 50 years old being type 2 diabetics present with frecuency diabetic foot ulcer. The majority of patients treated with Heberprot-P® healed and there were few amputations.
Keywords : ulcer; diabetic foot; Heberprot-P®.